Lates News

Every Interaction AI Fast News, Guojin Securities released a research report on August 22 giving a buy rating to Antu Bio (603658.SH). The reasons for the rating mainly include: 1) Short-term demand pressure in the domestic market, market share consolidation and improvement; 2) Continuous high research and development investment, new field expansion is expected to gradually contribute to long-term growth. (Daily Economic News)